• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.25% Nasdaq Up0.65%

    Agios Pharmaceuticals, Inc. (AGIO)

    -NasdaqGS
    53.34 Up 0.44(0.83%) May 27, 4:00PM EDT
    |After Hours : 53.33 Down 0.01 (0.02%) May 27, 4:34PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
    Total Revenue 31,281   6,218   5,480   13,219  
    Cost of Revenue -   -   -   -  
    Gross Profit 31,281   6,218   5,480   13,219  
    Operating Expenses
    Research Development44,038  36,933  36,028  36,423  
    Selling General and Administrative10,837  10,183  9,926  8,929  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (23,594) (40,898) (40,474) (32,133)
    Income from Continuing Operations
    Total Other Income/Expenses Net396  276  218  236  
    Earnings Before Interest And Taxes(23,198)(40,622)(40,256)(31,897)
    Interest Expense -   -   -   -  
    Income Before Tax(23,198)(40,622)(40,256)(31,897)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(23,198)(40,622)(40,256)(31,897)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (23,198) (40,622) (40,256) (31,897)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (23,198) (40,622) (40,256) (31,897)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.